A Phase 1 Study of CS-3150 Evaluation of Safety, Pharmacokinetics, and Pharmacodynamics after Single Oral Administration in Japanese Healthy Adult Male Subjects

Trial Profile

A Phase 1 Study of CS-3150 Evaluation of Safety, Pharmacokinetics, and Pharmacodynamics after Single Oral Administration in Japanese Healthy Adult Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Apr 2018

At a glance

  • Drugs Esaxerenone (Primary)
  • Indications Diabetic nephropathies; Essential hypertension; Hyperaldosteronism; Hypertension
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 24 Apr 2018 Results of pooled data from two phase1 single and multiple dose trial (JapicCTI163473 and JapicCTI163476) assessing pharmacokinetics, pharmacodynamics, and safety of oral esaxerenone in healthy Japanese subjects, were published in the British Journal of Clinical Pharmacology.
    • 27 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top